Cargando…
Myeloid leukaemia following therapy for a first primary cancer.
To evaluate the risk of second primary myeloid leukaemia due to radiotherapy and chemotherapy administered for a first primary cancer, we conducted a population-based case-control study consisting of 97 cases and 194 controls matched on age, date of diagnosis, and site of initial primary cancer amon...
Autores principales: | Nandakumar, A., Davis, S., Moolgavkar, S., Witherspoon, R. P., Schwartz, S. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972376/ https://www.ncbi.nlm.nih.gov/pubmed/2039704 |
Ejemplares similares
-
Molecular Mechanisms and Therapies of Myeloid Leukaemia
por: Brown, Elliott, et al.
Publicado: (2022) -
Acute Myeloid Leukaemia: New Targets and Therapies
por: Brown, Geoffrey, et al.
Publicado: (2017) -
Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma
por: Saso, R, et al.
Publicado: (2000) -
Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980) -
Myeloid Leukæmia Treated by Deep X-Ray Therapy
por: Mallick, S. M. K., et al.
Publicado: (1938)